Patients with relapsing blood-related cancers will now receive additional treatment Related items from OnMedica Prophylactic antibiotics help children with leukaemia Study shows huge global variation in cancer drug costs Regulator reverses decision on leukaemia drug Funding boost for local cancer services |
No comments:
Post a Comment